VP2HF

Computer model derived indices for optimal patient-specific treatment selection and planning in Heart Failure

 Coordinatore KING'S COLLEGE LONDON 

 Organization address address: Capital House, Weston St 42
city: London
postcode: SE1 3QD

contact info
Titolo: Mr.
Nome: Paul
Cognome: Labbett
Email: send email
Telefono: 442078184
Fax: 442078187

 Nazionalità Coordinatore United Kingdom [UK]
 Totale costo 5˙033˙161 €
 EC contributo 3˙562˙998 €
 Programma FP7-ICT
Specific Programme "Cooperation": Information and communication technologies
 Code Call FP7-ICT-2013-10
 Funding Scheme CP
 Anno di inizio 2013
 Periodo (anno-mese-giorno) 2013-10-01   -   2016-09-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    KING'S COLLEGE LONDON

 Organization address address: Capital House, Weston St 42
city: London
postcode: SE1 3QD

contact info
Titolo: Mr.
Nome: Paul
Cognome: Labbett
Email: send email
Telefono: 442078184
Fax: 442078187

UK (London) coordinator 0.00
2    CENTRON DIAGNOSTICS LTD

 Organization address address: BROMLEY LANE 1 CHISLEHURST BUSINESS
city: CHISLEHURST KENT
postcode: BR7 6LH

contact info
Titolo: Mr.
Nome: Christopher
Cognome: Lawson
Email: send email
Telefono: +44 7891160593

UK (CHISLEHURST KENT) participant 0.00
3    CHU COTE DE NACRE - CAEN

 Organization address address: AVENUE DE LA COTE DE NACRE
city: CAEN CEDEX 5
postcode: 14033

contact info
Titolo: Ms.
Nome: Cathy
Cognome: Gaillard
Email: send email
Telefono: +33 2 31 06 53 49

FR (CAEN CEDEX 5) participant 0.00
4    INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET EN AUTOMATIQUE

 Organization address address: Domaine de Voluceau, Rocquencourt
city: LE CHESNAY Cedex
postcode: 78153

contact info
Titolo: Mrs.
Nome: Mireille
Cognome: Moulin
Email: send email
Telefono: +33 172925962
Fax: +33 1 74 85 42 42

FR (LE CHESNAY Cedex) participant 0.00
5    PHILIPS FRANCE

 Organization address address: rue de Verdun
city: SURESNES
postcode: 92156

contact info
Titolo: Mr.
Nome: Pascal
Cognome: Behier
Email: send email
Telefono: +33 147281230

FR (SURESNES) participant 0.00
6    PHILIPS TECHNOLOGIE GMBH

 Organization address address: LUEBECKERTORDAMM
city: HAMBURG
postcode: 20099

contact info
Titolo: Mr.
Nome: Patrick
Cognome: Keur
Email: send email
Telefono: +31 40 5740361

DE (HAMBURG) participant 0.00
7    SIMULA RESEARCH LABORATORY AS

 Organization address address: MARTIN LINGES VEI
city: SNAROYA
postcode: 1367

contact info
Titolo: Dr.
Nome: Samuel
Cognome: Wall
Email: send email
Telefono: +47 986 29 471

NO (SNAROYA) participant 0.00
8    UNIVERSITAT POMPEU FABRA

 Organization address address: PLACA DE LA MERCE 10-12
city: BARCELONA
postcode: 8002

contact info
Titolo: Mrs.
Nome: Eva
Cognome: Martin
Email: send email
Telefono: +34 93 542 2140
Fax: +34 93 542 1440

ES (BARCELONA) participant 0.00
9    UNIVERSITE CATHOLIQUE DE LOUVAIN

 Organization address address: Place De L'Universite
city: LOUVAIN-LA-NEUVE
postcode: 1348

contact info
Titolo: Prof.
Nome: Jean-Louis
Cognome: Vanoverschelde
Email: send email
Telefono: +32 2 7642859
Fax: +32 27648980

BE (LOUVAIN-LA-NEUVE) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

prospective    hf    statistical    vp    models    add    biophysical    significant    patients    parts    tools    impact    decision    clinical    therapy    substantial    workflow   

 Obiettivo del progetto (Objective)

Heart failure (HF) is one of the major health issues in Europe affecting 6 million patients and growing substantially because of the ageing population and improving survival following myocardial infarction. The poor short to medium term prognosis of these patients means that, treatments such as cardiac re-synchronisation therapy and mitral valve repair can have substantial impact. However, these therapies, are ineffective in up to 50% of the treated patients and involve significant morbidity and substantial cost. The primary aim of VP2HF is to bring together image and data processing tools with statistical and integrated biophysical models mainly developed in previous VPH projects, into a single clinical workflow to improve therapy selection and treatment optimisation in HF. The tools will be tested and validated in 200 patients (including 50 historical datasets) across 3 clinical sites, including a prospective clinical study in 50 patients in the last year of the project. The key innovations in VP2HF that make it likely that the project results will be commercially exploited and have major clinical impact are; 1) all tools to process images and signals, and obtain the statistical and biophysical models will be integrated into one clinical software platform that can be easily and intuitively used by clinicians and tried out in the prospective clinical study and 2) by utilising a decision tree stratification approach, only the appropriate parts of the tool chain, that will add maximum value to the predictions will be used in individual patients, so that the more resource intensive parts will be used when they will add real value. We expect that the study results of substantial improved efficacy of decision making over current guidelines, and an integrated package that is used as part of clinical workflow will ensure the industrial project partners, in particular Philips, will develop project outputs into dedicated products that will have significant clinical impact.

Altri progetti dello stesso programma (FP7-ICT)

ACTORS (2008)

Adaptivity and Control of Resources in Embedded Systems

Read More  

III-V-MOS (2013)

Technology CAD for III-V Semiconductor-based MOSFETs

Read More  

TDK4PE (2011)

Technology & Design Kits for Printed-Electronics

Read More